CARDIOL THERAPEUTICS INC. (CRDL)
Clinical trial NCT06499714 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2025-08-31 3. primary completion date: 2025-12-31 → 2025-08-31 4. enrollment: 90 → 91 participants 5. enrollment type: ESTIMATED → ACTUAL
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical